Výsledky vyhledávání - "Norma J, Ofsthun"

Akademický článek

Kidney Health Initiative ESKD Data Standards Project

Autor: Lorien S. Dalrymple, Eric W. Young, Youssef MK. Farag, Michael J. Fischer, Emel Hamilton, Wael F. Hussein, Eduardo Lacson, Jr., Norma J. Ofsthun, Francesca Tentori, Melissa West

Publikováno v: Kidney Medicine, Vol 4, Iss 8, Pp 100495- (2022)

The end-stage kidney disease (ESKD) Data Standards Project was launched by the Kidney Health Initiative (KHI) with the goal of standardizing dialysis-related measurements for research use. KHI is a public-private partnership between the American Soci

Externí odkaz: https://doaj.org/article/fea67f0b32bc4748832e00af0043107a

Zobrazit plný text záznamu

Mineral bone disease in autosomal dominant polycystic kidney disease

Autor: Franklin W. Maddux, Theodore I. Steinman, Myles Wolf, Diana George, Isidro B. Salusky, Harmut H. Malluche, Vicente E. Torres, Norma J. Ofsthun, Michel Chonchol, Tamara Isakova, Renata C. Pereira, Lorien S. Dalrymple, Jason W Stoneback, Arlene B. Chapman, Berenice Gitomer, Xuan Cai, Zhiying You

Publikováno v: Kidney Int

Mice with disruption of Pkd1 in osteoblasts demonstrate reduced bone mineral density, trabecular bone volume and cortical thickness. To date, the bone phenotype in adult patients with autosomal dominant polycystic kidney disease (ADPKD) with stage I

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3459bd930f43b0ed59d2353d3d79adb3
https://doi.org/10.1016/j.kint.2020.07.041

Zobrazit plný text záznamu

Mortality and Hospitalizations among Sickle Cell Disease Patients with End-Stage Kidney Disease Initiating Dialysis

Autor: Lorien S. Dalrymple, Nwamaka D. Eneanya, Sophia H. Zhao, Sagar U. Nigwekar, Norma J. Ofsthun, Ravi Thadhani, Franklin W. Maddux, Kabir O. Olaniran

Publikováno v: American Journal of Nephrology. 51:995-1003

Background: Sickle cell disease (SCD) is the most common inherited hematological disorder and a well-described risk factor for end-stage kidney disease (ESKD). Mortality and hospitalizations among patients with SCD who develop ESKD remain understudie

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8832e83591f0d2685ba677c0154b663b
https://doi.org/10.1159/000513012

Zobrazit plný text záznamu

Conversion from Intravenous Vitamin D Analogs to Oral Calcitriol in Patients Receiving Maintenance Hemodialysis

Autor: Franklin W. Maddux, Lorien S. Dalrymple, Len A. Usvyat, Sophia Rosen, Jeffrey Hymes, Ravi Thadhani, Norma J. Ofsthun

Publikováno v: Clin J Am Soc Nephrol

BACKGROUND AND OBJECTIVES: In the United States, intravenous vitamin D analogs are the first-line therapy for management of secondary hyperparathyroidism in hemodialysis patients. Outside the United States, oral calcitriol (1,25-dihydroxyvitamin D(3)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5c507f580287b6b3ae52ea054b0271e
https://europepmc.org/articles/PMC7057297/

Zobrazit plný text záznamu

Real-world effectiveness of sucroferric oxyhydroxide in patients on chronic hemodialysis: A retrospective analysis of pharmacy data

Autor: Norma J. Ofsthun, Daniel W. Coyne, Sharanya Vemula, Ludmila Anderson, Franklin W. Maddux, Claudy Mullon, Stuart M. Sprague, Robert J. Kossmann, Linda H. Ficociello, Vidhya Parameswaran

Publikováno v: Clinical Nephrology

Aims: Hyperphosphatemia has been associated with an increased risk of mortality in patients with end-stage renal disease. We sought to assess the real-world effectiveness of sucroferric oxyhydroxide (SO), an iron-based phosphate binder (PB), in contr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f00dbfaed71025ddb26bfa9b3325b687
http://europepmc.org/articles/PMC5514614

Zobrazit plný text záznamu

One-Year Historical Cohort Study of the Phosphate Binder Sucroferric Oxyhydroxide in Patients on Maintenance Hemodialysis

Autor: Kamyar Kalantar-Zadeh, Jessica Kendrick, Linda H. Ficociello, Vidhya Parameswaran, Shannon Davis, Claudy Mullon, Robert J. Kossmann, Norma J. Ofsthun

Publikováno v: Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation, vol 29, iss 5
Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation

OBJECTIVE:The high pill burden of many phosphate binders (PBs) may contribute to increased prevalence of hyperphosphatemia and poor nutritional status observed among patients undergoing maintenance hemodialysis therapy. We examined the real-world eff

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::066cedd522bf977bc902e32324ee1d60
https://escholarship.org/uc/item/3bv8n0gm

Zobrazit plný text záznamu

Real-World Scenario Improvements in Serum Phosphorus Levels and Pill Burden in Peritoneal Dialysis Patients Treated with Sucroferric Oxyhydroxide

Autor: Claudy Mullon, Linda H. Ficociello, Vidhya Parameswaran, Kamyar Kalantar-Zadeh, Christopher Kwoh, Ludmila Anderson, Daniel W. Coyne, Robert J. Kossmann, Norma J. Ofsthun

Publikováno v: American journal of nephrology. 47(3)

Background: A database analysis was conducted to assess the effectiveness of sucroferric oxyhydroxide (SO) on lowering serum phosphorus and phosphate binder (PB) pill burden among adult peritoneal dialysis (PD) patients prescribed SO as part of routi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1e2acb7595a3d6f2d6f938602be1f53
https://pubmed.ncbi.nlm.nih.gov/29514139

Zobrazit plný text záznamu

Intensive Hemodialysis Associates with Improved Survival Compared with Conventional Hemodialysis

Publikováno v: Journal of the American Society of Nephrology. 23:696-705

Patients undergoing conventional maintenance hemodialysis typically receive three sessions per week, each lasting 2.5–5.5 hours. Recently, the use of more intensive hemodialysis (>5.5 hours, three to seven times per week) has increased, but the eff

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::fb95c1b1f9c0f114212deffe386e4c64
https://doi.org/10.1681/asn.2011070676

Zobrazit plný text záznamu

Application of Kinetic Modeling to Mineral Metabolism Management

Autor: Norma J. Ofsthun, Amanda K. Stennett, Frank A. Gotch

Publikováno v: Seminars in Dialysis. 24:580-586

Patients with CKD face many consequences of renal failure, including disorders of bone and mineral metabolism. The current approach to management of these mineral metabolism issues lacks comprehensive quantitative assessment, so a kinetic modeling pr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::98d456c4465c7869360a2598c93a061b
https://doi.org/10.1111/j.1525-139x.2011.00972.x

Zobrazit plný text záznamu

Anemia Management in Patients Receiving Chronic Hemodialysis

Autor: Mayuri Thakuria, Norma J. Ofsthun, Claudy Mullon, Jose A. Diaz-Buxo

Publikováno v: Seminars in Dialysis. 24:597-602

Anemia treatment in hemodialysis-dependent (HDD) CKD patients involves adequate supply of iron and an erythropoiesis-stimulating agent (ESA). Despite widespread usage of these agents, there is no generally accepted "standard dosing algorithm" for tre

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::17fb80bd20521987a2acd6f4a1ef46b6
https://doi.org/10.1111/j.1525-139x.2011.00975.x

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání